Category: MassDevice.com Earnings Roundup
Alere says it plans to sell its health-management unit to Optum for $600 million in cash in order to focus on its core rapid diagnostics business.
Alere agreed to sell Alere Health, its health-management unit, to health-services provider Optum for $600 million in cash in order to focus on its core rapid diagnostics business.
Edwards Lifesciences reports 3rd-quarter sales and earnings growth in excess of 20% and raises its outlook for the rest of the year.
The CEOs of medical device companies Boston Scientific and C.R. Bard are cool on the consolidation trend in medtech, saying they don't see the need for mega-deals to grow their businesses.
C.R. Bard reports a 3rd-quarter earnings gain of nearly 50% and raises its guidance for the rest of the year, sending share prices up this morning on Wall Street.
C.R. Bard (NYSE:BCR) shares are up more than 3% this morning on Wall Street after the medical device company reported that its 3rd-quarter earnings rose 47.0% compared with the same period last year.
Zimmer Holdings says its 3rd-quarter earnings beat expectations and narrows its sales and earnings guidance for the rest of the year.
Zimmer's (NYSE:ZMH) 3rd-quarter earnings came in ahead of expectations on strong performances from its core knee and hip implant businesses.
Abbott says it will go ahead with its plan to deal its generic pharmaceuticals line to Mylan for $5.3 billion and reports 3rd-quarter sales in line with expectations.
Sales of its cardiac rhythm management devices help boost Boston Scientific above expectations for the 3rd quarter.